$CTA-PB 3 SEC Filings

Filed On	Filing
10 Jun 2019	Form 3: Glenn Timothy P, See Remarks No securities owned
10 Jun 2019	Form 3: Titus Brian, See Remarks No securities owned
10 Jun 2019	Form 3: Gutterson Neal, See Remarks No securities owned
10 Jun 2019	Form 3: Gajaria Rajan, See Remarks No securities owned
10 Jun 2019	Form 3: Fuerer Cornel B, See Remarks No securities owned
10 Jun 2019	Form 3: Cassidy Meghan, See Remarks No securities owned
10 Jun 2019	Form 3: Friedman Gregory R, Director No securities owned
10 Jun 2019	Form 3: Collins James C. Jr., Director No securities owned
14 Dec 2015	Form 3: Doyle Christopher Marc, Senior Vice President Holds 81,503.3975 shares of Common Stock
17 Jun 2015	Form 3: Dupont E I De Nemours & Co, 10% owner · The Chemours Company Holds 100 shares of Common Stock
17 Feb 2015	Form 3: Gallogly James L, Director No securities owned
17 Feb 2015	Form 3: Breen Edward D, Director No securities owned
10 Dec 2014	Form 3: Trerotola Matthew L., Executive Vice President Holds 44,712.4469 shares of Common Stock
10 Dec 2014	Form 3: Muzyka Douglas W., SVP & Chief S&T Officer Holds 34,386.2819 shares of Common Stock
10 Dec 2014	Form 3: Collins James C. Jr., Executive Vice President Holds 71,954.0074 shares of Common Stock
23 Oct 2014	Form 3: Schneider Ulf M., Director No securities owned
08 Oct 2014	Form 3: Fox Stacy L, SVP & General Counsel No securities owned
25 Jun 2014	Form 3: Rees Martha L., VP & Acting General Counsel Holds 15,325.1144 shares of Common Stock
28 Oct 2013	Form 3: Ward Pat, Director No securities owned
03 May 2012	Form 3: Andreotti Lamberto, Director No securities owned

Comments